MediFormatica的动态

American Alternative Capital is proud to serve as the managing broker-dealer for HPA Exchange, a sponsor of healthcare real estate investment offerings. This partnership combines AAC’s expertise in alternative investments with HPA Exchange’s focus on institutional-quality healthcare real estate. HPA Exchange specializes in medical properties anchored by institutional-quality tenants, including investment-grade healthcare systems, physician groups, and life science organizations. Their offerings target markets with tailored growth potential, seeking to deliver long-term, potential cash flow opportunities for investors. As part of this collaboration, AAC is dedicated to providing financial advisors, registered investment advisory firms, and broker-dealers with access to these carefully selected healthcare real estate investment opportunities. Together, we’re helping diversify portfolios with assets designed with the potential for stability and growth. #AmericanAlternativeCapital #ExpertiseDrivingOpportunity #Opportunity #Connection #AlternativeInvestments #Investments #HPAExchange #HealthcareRealEstate #InvestmentOpportunities #BrokerDealerPartnership #BrokerDealer

Deal making within healthcare in the first half of 2024 saw an increase in activity relative to 2023, espicially within IPOs, venture, and PIPEs/RDOs; however, the performance of healthcare equties has lagged behind the overall market as risk-aversion remains pervasive. For a full breakdown of the performance of healthcare equities and deal making across IPOs, Follow-Ons, PIPEs/RDOs, M&A, Licensing, and Venture see the full H1 report below that I assembled alongside my investment banking colleagues at Back Bay Life Science Advisors. US & EU Healthcare 2024 H1 Review ?? https://lnkd.in/epJXC9Ng

We are pleased to release our review of M&A, private equity and venture capital activity across the UK healthcare sector in Q2 of 2024. Our report, which can be found below, highlights the most active sub-sectors, along with a month-by-month summary of the key deals across the market. #healthcare #privateequity #venturecapital #corporatefinance #investmentbanking #mergersandacquisitions #mergersacquisitionsdivestitures

Here is a fun one on continuation funds! We haven't seen a ton of activity in healthcare but I expect that we will see a lot more activity as the portfolio management aspect of private equity becomes more and more complex. This might be the "forever home" for some of the mature healthcare platform investments out there. It will be interesting to see the cap table on some of these continuation funds, SPVs, etc. #healthcare #healthcaremanda #mergersandacquisitions #investmentbanking #healthcaretransactions

We are pleased to release our review of M&A, private equity and venture capital activity across the UK healthcare sector in Q1 of 2024. Our report, which can be found below, highlights the most active sub-sectors, along with a month-by-month summary of the key deals across the market. #healthcare #privateequity #venturecapital #corporatefinance #investmentbanking #mergersandacquisitions #mergersacquisitionsdivestitures

Global healthcare private equity deal activity surged in 2024, driven by a wave of megadeals. The year marked the second-highest activity on record in North America and a record-breaking performance in Europe. Explore our annual report https://bit.ly/3Pva1V0

Healthcare News: Baird Capital invests in Newmarket Strategy. Baird Capital has invested in independent health and life sciences consultancy and market access specialist Newmarket Strategy. Financial details of the transaction have not been disclosed. The growth capital investment from Baird Capital’s Global Private Equity Fund will be used to support Newmarket’s continued growth. Founded in 2021, Newmarket works with clients across the health […] #healthcare https://ow.ly/9aYa105WmLK

From our just-released 2025 HCPE report... mid-market healthcare private equity funds are thriving, outperforming larger funds and sustaining deal volume. Read about how many firms are evolving their strategies to stay ahead. https://bit.ly/3E4MF65

Marco Toni, Nicolas Wehrli, Gilles Pitschen and Pascal Hammerer have contributed to the Swiss chapter of the 2024 Healthcare M&A Chambers Global Practice Guide. ? The guide provides the latest legal information on market trends, establishing healthcare start-ups, including early-stage financing and venture capital, IPOs and private sales, spin-offs, acquisition of listed companies, including stakebuilding, documentation, squeeze-out mechanisms, certain funds requirements and deal protection measures, regulatory requirements, including antitrust, foreign investment review and data privacy concerns, disclosure obligations, and duties of directors. ? Click here to read the full chapter: https://lawand.tax/3RAAfah ? #healthcare #lifesciences #Switzerland #lawandtax

Global healthcare private equity deal activity surged in 2024, driven by a wave of megadeals. The year marked the second-highest activity on record in North America and a record-breaking performance in Europe. Explore our annual report to uncover what’s next for the market and the key trends shaping dealmaking. https://bit.ly/4gNEWIr